company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,79116705.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4495792.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,83849.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4317105.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,88013451.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1495639.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,,totalassets,Total Assets,=,debit,usd,89509090.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1731663.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9465723.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,20345671.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,31543057.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,37912637.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,37912637.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,69455694.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,251824621.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-231771225.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,20053396.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,20053396.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,20053396.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q2,,2011-06-30,2011-08-05 16:25:07+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,89509090.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,66329358.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6237904.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,103443.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4297814.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,76968519.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1274753.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,,totalassets,Total Assets,=,debit,usd,78243272.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1219905.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8864705.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3707795.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13792405.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,37395704.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,37395704.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,51188109.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,253661195.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-226606032.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,27055163.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,27055163.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,27055163.0
Halozyme Therapeutics Inc,HALO,,0001159036,2011.0,Q3,,2011-09-30,2011-11-08 16:29:40+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,78243272.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,116608304.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5550830.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1496783.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8910059.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,132565976.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2152934.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,,totalassets,Total Assets,=,debit,usd,134718910.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3011181.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7184794.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6484800.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16680775.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,36977724.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,36977724.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,53658499.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,341201238.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-260140827.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,81060411.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,81060411.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,81060411.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q1,,2012-03-31,2012-05-07 16:59:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,134718910.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,102041617.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5687096.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1783894.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10218468.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,119731075.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2016809.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,,totalassets,Total Assets,=,debit,usd,121747884.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2087432.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7529322.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6530834.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16147588.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,36365978.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,36365978.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,52513566.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,343396264.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-274161946.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,69234318.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,69234318.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,69234318.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q2,,2012-06-30,2012-08-09 09:02:03+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,121747884.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,87614891.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4464273.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,2186063.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,11353342.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,105618569.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2363650.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,,totalassets,Total Assets,=,debit,usd,107982219.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3526839.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8041673.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9470247.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,21038759.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,35753683.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,35753683.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,56792442.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,345357569.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-294167792.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,51189777.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,51189777.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,51189777.0
Halozyme Therapeutics Inc,HALO,,0001159036,2012.0,Q3,,2012-09-30,2012-11-08 17:01:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,107982219.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,39017804.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,48408220.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,10375733.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,2737387.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10571334.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,111110478.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3975052.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1280765.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1780765.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,,totalassets,Total Assets,=,debit,usd,116866295.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1362055.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2884794.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9177574.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6326158.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,19750581.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,28323233.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,1450000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,35224572.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,436849.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,65434654.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,85185235.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,349572208.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-317862017.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-29131.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,31681060.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,31681060.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,31681060.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q1,,2013-03-31,2013-05-08 17:27:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,116866295.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,27927551.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,48082636.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,10831828.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,2466999.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,11111833.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,100420847.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4576506.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1889985.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2389985.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,,totalassets,Total Assets,=,debit,usd,107387338.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3643156.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7480982.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,15289431.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6419681.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,32833250.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,26075507.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,2100000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,34556204.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,678700.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,63410411.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,96243661.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,351956514.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-340773528.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-39309.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,11143677.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,11143677.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,11143677.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q2,,2013-06-30,2013-08-07 17:07:20+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,107387338.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,17492131.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,47818851.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,24521742.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,3846290.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9139014.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,102818028.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4935928.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1891170.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2391170.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,,totalassets,Total Assets,=,debit,usd,110145126.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,5970119.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5591763.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,20624501.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,7437433.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,39623816.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,23781955.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,2550000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,46754200.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,921460.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,74007615.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,113631431.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,356563812.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-360065896.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,15779.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-3486305.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-3486305.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-3486305.0
Halozyme Therapeutics Inc,HALO,,0001159036,2013.0,Q3,,2013-09-30,2013-11-08 16:32:54+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,110145126.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,76570000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,87919000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,10956000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,6765000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8704000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,190914000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3628000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2645000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3145000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,,totalassets,Total Assets,=,debit,usd,197687000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2404000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8658000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12272000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,13026000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,36360000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,47389000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,44847000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2343000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,94579000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,130939000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,475373000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-408600000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-25000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,66748000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,66748000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,66748000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q1,,2014-03-31,2014-05-12 16:36:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,197687000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,56135000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,91513000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,12895000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,7114000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7966000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,175623000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3343000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2586000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3086000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,,totalassets,Total Assets,=,debit,usd,182052000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,6203000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3910000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,16455000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,5153000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,31721000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,43613000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,48565000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2854000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,95032000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,126753000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,480169000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-424873000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,3000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,55299000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,55299000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,55299000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q2,,2014-06-30,2014-08-11 16:29:46+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,182052000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,46375000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,88089000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,8275000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,6916000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8945000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,158600000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3249000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2277000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2777000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,,totalassets,Total Assets,=,debit,usd,164626000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,10075000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4342000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,15023000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,5153000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,34593000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,39762000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,47572000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2759000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,90093000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,124686000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,485139000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-445153000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-46000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,39940000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,39940000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,39940000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2014.0,Q3,,2014-09-30,2014-11-10 16:48:11+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,164626000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,44287000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,84212000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7725000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,7482000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9623000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,153329000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2732000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2564000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3064000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,,totalassets,Total Assets,=,debit,usd,159125000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3730000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3299000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12813000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6367000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,26209000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,45985000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,46259000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3127000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,95371000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,121580000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,503107000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-465535000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-27000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,37545000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,37545000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,37545000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q1,,2015-03-31,2015-05-11 16:17:32+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,159125000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,67769000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,72946000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,9738000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,7723000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10266000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,168442000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2594000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2511000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3011000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,,totalassets,Total Assets,=,debit,usd,174047000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,9656000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4138000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,14821000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6424000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,35039000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,40098000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,45252000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3429000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,88779000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,123818000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,512785000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-462516000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-40000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,50229000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,50229000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,50229000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q2,,2015-06-30,2015-08-10 16:15:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,174047000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,71514000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,52204000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,8392000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,11101000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9879000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,153090000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2686000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2458000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2958000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,,totalassets,Total Assets,=,debit,usd,158734000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,15699000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4437000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,18926000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,5789000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,44851000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,34094000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,44244000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3746000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,82084000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,126935000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,518775000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-486976000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,31799000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,31799000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,31799000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2015.0,Q3,,2015-09-30,2015-11-09 16:10:31+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,158734000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,69093000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,169545000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,25543000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,10345000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,22509000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,297035000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4440000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,7121000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,7621000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,,totalassets,Total Assets,=,debit,usd,309096000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,27417000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6211000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,21791000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,8804000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,64223000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,168600000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,42895000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3906000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,215401000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,279624000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,531519000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-502135000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,88000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,29472000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,29472000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,29472000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q1,,2016-03-31,2016-05-09 16:34:10+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,309096000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,61233000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,168757000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,23227000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,10755000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,20372000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,284344000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4682000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6601000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,7101000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,,totalassets,Total Assets,=,debit,usd,296127000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3288000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3650000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,23851000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,8096000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,38885000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,204850000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,41872000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,600000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,247322000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,286207000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,538714000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-529010000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,216000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,9920000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,9920000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,9920000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q2,,2016-06-30,2016-08-09 16:09:25+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,296127000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,61207000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,159845000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,17679000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,12852000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,21022000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,272605000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4407000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4986000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5486000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,,totalassets,Total Assets,=,debit,usd,282498000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,12394000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4641000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,25733000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9892000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,52660000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,199803000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,40849000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1178000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,241830000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,294490000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,545880000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-557955000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,83000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-11992000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-11992000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-11992000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2016.0,Q3,,2016-09-30,2016-11-07 16:08:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,282498000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,45188000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,133797000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,12452000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,14290000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,16627000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,222354000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3741000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,172000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,672000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,,totalassets,Total Assets,=,debit,usd,226767000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,29601000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3079000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,24935000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4093000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,61708000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,184430000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,38802000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,326000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,223558000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,285266000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,559789000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-618239000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-49000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-58499000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-58499000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-58499000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q1,,2017-03-31,2017-05-09 16:23:25+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,226767000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,114745000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,182788000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,14473000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,15172000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,13656000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,340834000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3330000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,122000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,622000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,,totalassets,Total Assets,=,debit,usd,344786000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,45515000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5650000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,26934000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4516000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,82615000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,165517000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,37779000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,710000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,204006000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,286621000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,707228000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-649002000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-61000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,58165000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,58165000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,58165000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q2,,2017-06-30,2017-08-08 16:13:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,344786000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,164397000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,152525000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,14695000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,9331000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,12397000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,353345000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3232000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,72000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,572000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,,totalassets,Total Assets,=,debit,usd,357149000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,61433000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4152000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,32370000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4093000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,102048000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,145417000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,36755000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,540000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,182712000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,284760000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,718695000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-646253000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-53000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,72389000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,72389000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,72389000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2017.0,Q3,,2017-09-30,2017-11-07 16:14:33+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,357149000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,98012000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,335682000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,26574000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,4393000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,19809000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,484470000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4937000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5562000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,6062000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,,totalassets,Total Assets,=,debit,usd,495469000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,82460000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3628000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,31889000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1247000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,119224000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,102696000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6006000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2479000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,111181000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,230405000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,744503000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-478569000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-870000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,265064000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,265064000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,265064000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q1,,2018-03-31,2018-05-10 16:37:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,495469000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,55173000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,343721000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,33582000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,8404000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,21152000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,462032000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4789000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,7433000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,7933000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,,totalassets,Total Assets,=,debit,usd,474754000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,86965000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6187000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,35030000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4247000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,132429000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,79080000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6006000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2314000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,87400000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,219829000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,757122000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-501461000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-736000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,254925000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,254925000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,254925000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q2,,2018-06-30,2018-08-07 16:29:38+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,474754000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,55019000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,309347000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,27656000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,18285000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,19619000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,429926000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6790000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,7291000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,7791000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,,totalassets,Total Assets,=,debit,usd,444507000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,88521000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3331000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,43020000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4247000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,139119000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,57940000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5507000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2203000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,65650000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,204769000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,769527000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-529311000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-478000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,239738000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,239738000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,239738000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2018.0,Q3,,2018-09-30,2018-11-06 16:14:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,444507000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,60595000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,268122000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,28164000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,31241000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,20914000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,409036000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,14542000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5031000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5531000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,,totalassets,Total Assets,=,debit,usd,429109000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,86663000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4089000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,43663000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4247000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,138662000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,18742000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4509000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,7149000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,30400000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,169062000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,789628000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-529642000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,61000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,260047000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,260047000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,260047000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q1,,2019-03-31,2019-05-07 16:08:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,429109000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,67041000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,220424000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,32219000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,43900000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,28122000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,391706000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,15079000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10545000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,11045000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,,totalassets,Total Assets,=,debit,usd,417830000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,70878000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,12467000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,45561000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6511000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,135417000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,14083000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1746000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6532000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,22361000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,157778000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,803928000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-544266000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,390000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,260052000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,260052000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,260052000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q2,,2019-06-30,2019-08-06 16:18:23+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,417830000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,59202000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,178796000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,40744000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,36051000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,27248000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,342041000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,15398000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,12417000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,500000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12917000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,,totalassets,Total Assets,=,debit,usd,370356000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,54537000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4314000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,45679000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3511000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,108041000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,9308000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1247000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6407000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,16962000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,125003000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,814242000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-569281000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,392000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,245353000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,245353000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,245353000.0
Halozyme Therapeutics Inc,HALO,,0001159036,2019.0,Q3,,2019-09-30,2019-11-12 16:21:13+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,370356000.0
